Clark E. Tedford
Gründer bei Lumithera, Inc.
Profil
Clark E.
Tedford is the founder who founded Lumithera, Inc. in 2013, where he currently holds the titles of President, Chief Executive Officer & Director.
In his former jobs, he was President & Chief Executive Officer at Solentix BioSciences, Inc. from 2002 to 2003, and Executive Vice President-Research & Development at Gliatech, Inc. from 1993 to 2003.
He also held positions as Vice President-Research at Omeros Corp., Chief Science Officer & Vice President at PhotoThera, Inc., and Principal Scientist at Schering-Plough Research Institute.
Dr. Tedford received his undergraduate and doctorate degrees from the University of Iowa.
Aktive Positionen von Clark E. Tedford
| Unternehmen | Position | Beginn |
|---|---|---|
Lumithera, Inc.
 Lumithera, Inc. Medical SpecialtiesHealth Technology Lumithera, Inc. manufactures medical devices. It offers treatment for age-related macular degeneration. The company was founded by Clark E. Tedford, Graham Merry, James Carroll, Luis DeTaboada and Robert Dotson in 2013 and is headquartered in Poulsbo, WA. | Gründer | 01.01.2013 |
Ehemalige bekannte Positionen von Clark E. Tedford
| Unternehmen | Position | Ende |
|---|---|---|
PhotoThera, Inc.
 PhotoThera, Inc. Medical SpecialtiesHealth Technology PhotoThera, Inc. (Carlsbad, CA) is a privately-held medical device company that was founded by Jackson Streeter, MD. The Company is developing proprietary, noninvasive laser energy therapies that may revolutionize the clinical care and management of ischemic stroke, traumatic brain injury, global ischemia, and other conditions characterized by disturbances in cellular metabolic function. The Company's initial product, the NeuroThera Laser System, will focus on the Transcranial Laser Therapy (TLT) of acute ischemic stroke. Estimates show that, in the United States, there are more than 600,000 ischemic strokes annually, and that stroke is the leading cause of serious long-term disability. | Technik-/Wissenschafts-/F&E-Leiter | 25.12.2013 |
Gliatech, Inc.
 Gliatech, Inc. BiotechnologyHealth Technology Gliatech, Inc. engages in the discovery and development of bio surgery and pharmaceutical products. The company was founded on August 12, 1987 and is headquartered in Cleveland, OH. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
| Solentix BioSciences, Inc. | Präsident | 01.01.2003 |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
| OMEROS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Clark E. Tedford
| University of Iowa | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Gliatech, Inc.
Gliatech, Inc. BiotechnologyHealth Technology Gliatech, Inc. engages in the discovery and development of bio surgery and pharmaceutical products. The company was founded on August 12, 1987 and is headquartered in Cleveland, OH. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
| Solentix BioSciences, Inc. | |
PhotoThera, Inc.
PhotoThera, Inc. Medical SpecialtiesHealth Technology PhotoThera, Inc. (Carlsbad, CA) is a privately-held medical device company that was founded by Jackson Streeter, MD. The Company is developing proprietary, noninvasive laser energy therapies that may revolutionize the clinical care and management of ischemic stroke, traumatic brain injury, global ischemia, and other conditions characterized by disturbances in cellular metabolic function. The Company's initial product, the NeuroThera Laser System, will focus on the Transcranial Laser Therapy (TLT) of acute ischemic stroke. Estimates show that, in the United States, there are more than 600,000 ischemic strokes annually, and that stroke is the leading cause of serious long-term disability. | Health Technology |
Lumithera, Inc.
Lumithera, Inc. Medical SpecialtiesHealth Technology Lumithera, Inc. manufactures medical devices. It offers treatment for age-related macular degeneration. The company was founded by Clark E. Tedford, Graham Merry, James Carroll, Luis DeTaboada and Robert Dotson in 2013 and is headquartered in Poulsbo, WA. | Health Technology |